Summary
Over the last decade, drug discovery faced the problem of decreasing success rates which is mainly caused by the fact that numerous novel biological targets are reluctant to classic small molecule modulation. In particular, that holds true for PPIs and PRIs. Approaches that...
More information & hyperlinks
| Web resources: | http://www.grossmannlab.com |